Studies on blood enrichment and anti-tumor effects of combined Danggui Buxue Decoction,Fe and rhEPO based on colon cancer-related anemia model and gut microbiota modulation

作     者：SHI Xu-Qin ZHU Zhen-Hua YUE Shi-Jun TANG Yu-Ping CHEN Yan-Yan PU Zong-Jin TAO Hui-Juan ZHOU Gui-Sheng DUAN Jin-Ao SHI Xu-Qin;ZHU Zhen-Hua;YUE Shi-Jun;TANG Yu-Ping;CHEN Yan-Yan;PU Zong-Jin;TAO Hui-Juan;ZHOU Gui-Sheng;DUAN Jin-Ao

作者机构：Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrializationand Jiangsu Key Laboratory for High Technology Research of TCM Formulaeand National and Local Collaborative Engineering Center of Chinese Medicinal Resources Industrialization and Formulae Innovative MedicineNanjing University of Chinese MedicineNanjing 210023China School of Artificial Intelligence and Information TechnologyNanjing University of Chinese MedicineNanjing 210023China Institute of Mental HealthSuzhou Psychiatric HospitalSoochow University Affiliated Guangji HospitalSuzhou 215100China Key Laboratory of Shaanxi Administration of Traditional Chinese Medicine for TCM Compatibilityand State Key Laboratory of Research&Development of Characteristic Qin Medicine Resources(Cultivation)and Shaanxi Key Laboratory of Chinese Medicine Fundamentals and New Drugs Researchand Shaanxi Collaborative Innovation Center of Chinese Medicinal Resources IndustrializationShaanxi University of Chinese MedicineXi’an 712046China 

出 版 物：《Chinese Journal of Natural Medicines》 (中国天然药物（英文版）)

年 卷 期：2021年第19卷第6期

页      面：422-431页

核心收录：

学科分类：0710[理学-生物学] 1007[医学-药学(可授医学、理学学位)] 1006[医学-中西医结合] 1005[医学-中医学] 100706[医学-药理学] 1002[医学-临床医学] 0703[理学-化学] 100602[医学-中西医结合临床] 10[医学] 

基　　金：supported by the National Natural Science Foundation of China(Nos.81603257,81773882,81974522) National Key R&D Program of China(2019YFC.711000) Postgraduate Research&Practice Innovation Program of Jiangsu Province,Key Research and Development Program of Shaanxi Province(2019ZDLSF04-05) Discipline Innovation Team Program of Shaanxi University of Chinese Medicine(2019-YL10) and a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions(PAPD) 

主　　题：Danggui Buxue Decoction Cancer-related anemia Gut microbiota modulation Fe rhEPO 

摘      要：Colon cancer-related anemia(CCRA)is mainly caused by systemic inflammation,intestinal bleeding,iron deficiency and chemotherapy-induced myelosuppression in colon ***,the best therapeutic schedule and related mechanism on CCRA were still *** on blood enrichment and anti-tumor effects of combined Danggui Buxue Decoction(DBD),Fe and rhEPO based on CCRA and gut microbiota modulation were conducted in this ***,CCRA model was successfully induced by subcutaneous inoculation of CT-26 and ***,rhEPO+DBD high dosage+Fe(EDF)and rhEPO+DBD high dosage(ED)groups had the best blood enrichment ***,EDF group also showed antitumor *** sequencing results of gut microbiota showed that compared to P group,the relative abundances of Lachnospiraceae and opportunistic pathogen(Odoribacter)in ED and EDF groups were ***,EDF also decreased the relative abundances of cancer-related bacteria(Helicobacter,Lactococcus,Alloprevotella)and imbalance-inducing bacteria(Escherichia-Shigella and Parabacteroides)and increased the relative abundances of butyrate-producing bacteria(Ruminococcaceae_UCG-014),however,ED showed the opposite effects to EDF,this might be the reason of the smaller tumor volume in EDF *** findings proposed the best treatment combination of DBD,rhEPO and Fe in CCRA and provided theoretical basis and literature reference for CCRA-induced intestinal flora disorder and the regulatory mechanism of EDF.